Oncternal Therapeutics (NASDAQ:ONCT) Coverage Initiated by Analysts at StockNews.com
Equities research analysts at StockNews.com started coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Free Report) in a report issued on Sunday. The firm set a “hold” rating on the stock. Oncternal Therapeutics Price Performance Shares of ONCT opened at $0.53 on Friday. The stock has a market capitalization of $1.56 million, a price-to-earnings […]
